Le JOG a lu pour vous
Hall et al. Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial
S. Quesada
Voir le résumé
Perry et al. Short-course radiation plus Temozolomide in elderly patients with glioblastoma
L. Pabst
Voir le résumé
Goineau et al. Comprehensive Geriatric Assessment and quality of life after localized prostate cancer radiotherapy in elderly patients
M. Loo
Voir le résumé
Yusuf et al. Interim results of a Phase II Study of Hypofractionated radiotherapy with concurrent Temozolomide followed by adjuvant Temozolomide in patients over 70 years old with newly diagnosed Glioblastoma1
A. Thomas
Voir le résumé
Maebayashi et al. Significance of stereotactic body radiotherapy in older patients with early stage non-small cell lung cancer
W. Waissi
Voir le résumé
Wildes et al. Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group
I. Leonard-Lorant
Voir le résumé
Tsuchie et al. The prognostic significance of surgical treatment for excessive elderly patients with soft tissue sarcoma
J. Gantzer
Voir le résumé
Young et al. Radical cystectomy in the elderly - Is this a safe treatment option?
L. Bender
Voir le résumé
Kenzik et al. New-Onset Cardiovascular Morbidity in Older Adults With Stage I to III Colorectal Cancer 1
S. Muxel
Voir le résumé
Frasca et al. Alterations in comprehensive geriatric assessment decrease survival of elderly patient with cancer 1
S. Azan
Voir le résumé
Wildiers et al. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group 1
S. Azan, S. Muxel, M. Vinches
Voir le résumé
Chin-Yee N, et al. Cost analysis of the very elderly admitted to intensive care units
I. Leonard-Lorant
Voir le résumé
Agar MR, et al. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial
P. Trensz
Voir le résumé
Ghosh S, et al. Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma
M. Loo
Voir le résumé
Swanick CW, et al. Long-Term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study
W. Waissi
Voir le résumé
Cabannes-Hamy A, et al. Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies
L. Bender
Voir le résumé
Daste A, et al.Immune checkpoint inhibitors and elderly people: A review
S. Azan, S. Muxel, M. Vinches
Voir le résumé
Falandry C, et al. Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial 1
O. Le Saux
Lire l'Article
Alibhai SM, et al. Long-term impact of androgen-deprivation therapy on physical function and quality of life 1
Christophe Sajous
Lire l'Article
Minniti G, et al. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis 1
Ariane Lapierre
Lire l'Article
Kunkler IH, et al. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial 1
Audrey Claren
Lire l'Article
Chargari C, et al. Feasibility of radiation therapy in patients 90 years of age and older: A French multicentre analysis 1
Alexander Falk
Lire l'Article
Martin N, et al.High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma 1
Juliette Reure
Lire l'Article
Vamvakas L, et al. Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG) 1
Guillaume Beinse
Lire l'Article
Chavez-MacGregor M, et al. Trastuzumab-related cardiotoxicity among older patients with breast cancer 1
G. Cogniet, ASIO
Lire l'Article
Adamo V, et al. The risk of toxicities from Trastuzumab,
alone or in combination, in an elderly breast cancer population 1
E.Chartron, ASIO
Lire l'Article
Cunningham D, et al. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial 1
E.Deluche, ASIO
Lire l'Article
Hoppe S, et al. Functional decline in older patients with cancer receiving first-line chemotherapy
S.Bétrian, ASIO
Lire l'Article
Wildiers H, et al. End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position Article 1
Camille Chakiba, ASIO
Lire l'Article
Hershman DL, et al. Contraindicated Use of Bevacizumab and Toxicity in Elderly Patients With Cancer
Juliette Reure
Lire l'Article
Aparicio T, et al. Geriatric factors predict chemotherapy feasibility: Ancillary results of FFCD 2001-02 Phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly
Audrey Claren
Lire l'Article
Trebouet A, et al. Lymphoma occuring in patients over 90 years of age: charactecristics, outcomes and prognostic factors. A retrospective analysis of 234 cases from the LYSA
AT. Falk
Lire l'Article
D. Garbay, et al. Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival
O. Le Saux
Lire l'Article
Aparicio T, et al. Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients
R. Tanguy
Lire l'Article
Aparicio T, et al. Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First- Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients
O. Le Saux
Lire l'Article
Deschler B, et al. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
N. Marques
Lire l'Article
Howrey BT, et al. The Impact of PSA Screening on Prostate Cancer Mortality and Overdiagnosis of Prostate Cancer in the United States
R. Tanguy
Lire l'Article
Park JH, et al. Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract
O. Le Saux
Lire l'Article
Kenis C, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study
R. Tanguy
Lire l'Article
Lire l'Article
Lire l'Article
Lire l'Article
Lire l'Article
Lire l'Article
Lire l'Article
Aizer AA, et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer
N. Marques
Lire l'Article
Malmström A, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma : the Nordic randomised, phase 3 trial
R. Tanguy
Lire l'Article
Kluin-Nelemans HC, et al. Treatment of older patients with mantle-cell lymphoma
O. Le Saux
Lire l'Article
Jehn CF, et al. Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer
A. Ploquin
Lire l'Article
Proctor SJ, et al. Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study
O. Le Saux
Lire l'Article
Maemondo M, et al. First-Line Gefitinib in patients aged 75 and older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations – NEJ003 Study
C. Baldini
Lire l'Article
Bonomi MR, et al. Outcomes of elderly patients with stage IIIB-IV non-small cell lung cancer admitted to the intensive care unit
N. Marques
Lire l'Article
Extermann M, et al. Predicting the risk of chemotherapy toxicity in older Patients : the Chemotherapy Risk Assessment Scale for High-age patients (CRASH) score
S. Cousin
Lire l'Article
Soubeyran P, et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer
R. Tanguy
Lire l'Article
Jilani OK, et al. Radiation therapy is well tolerated and produces excellent local control rates in elderly patients with locally advanced head and neck cancers
X. Liem
Lire l'Article
Wilt TJ, et al. Radical prostatectomy versus observation for localized prostate cancer
R. Tanguy
Lire l'Article
Abraham et al. : Adjuvant chemotherapy for stage III colon cancer in the oldest old
J. Wassermann
Lire l'Article
Zhu J et al. : Carboplatin and Paclitaxel With vs Without Bevacizumab in Older Patients With Advanced Non–Small Cell Lung Cancer
R. Geiss
Lire l'Article
Soubeyran P et al. : Predictors of early death risk in older patients treated with first-line chemotherapy for cancer
J. Wassermann
Lire l'Article
Atagi et al. : Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)
F.-G. Riet
Lire l'Article
Biganzoli L et al. : Management of elderly patients with breast cancer : updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Lire l'Article
Perez-Larraya JG et al. : Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial
Lire l'Article
Van de Water W et al. : Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer
Lire l'Article
Zhu J, et al. : Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer
Lire l'Article
Peyrade F, et al : Schéma immuno-chimiothérapique atténué (R-miniCHOP) chez les patients âgés de plus de 80 ans avec un lymphome B diffus à grandes cellules : une étude de phase 2, multicentrique, en un seul bras
Lire l'Article
Seymour MT, et al. : Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2) : an open-label, randomised factorial trial
Lire l'Article
Perez-Larraya, et al. : Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status : An ANOCEF Phase II Trial
Lire l'Article
Hurria, et al. : Predicting Chemotherapy Toxicity in Older Adults With Cancer : A Prospective Multicenter Study
Lire l'Article
Caillet et al. : Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer : ELCAPA Study
